Glycolipid Disialoganglioside-directed Antibody drugs

2 medications in the FDA established pharmacologic class “Glycolipid Disialoganglioside-directed Antibody”.

DrugTypeNDC products
Danyelza
Naxitamab
Rx1
Unituxin
Dinutuximab
Rx1